Combining PSMA-PET and PROMISE to re-define disease stage and risk in patients with prostate cancer: a multicentre retrospective study

Madeleine J. Karpinski, Johannes Hüsing, Kevin Claaßen, Lennart Möller, Hiltraud Kajüter, Florian Oesterling, Viktor Grünwald, Lale Umutlu, Jens Kleesiek, Tuğçe Telli, Anja Merkel‐Jens, Anika Hüsing, Claudia Kesch, Ken Herrmann, Matthias Eiber, Sebastian Hoberück, Philipp T. Meyer, Felix Kind, Kambiz Rahbar, Michael Schäfers, Andreas Stang, Boris Hadaschik, Wolfgang P. FendlerThe Lancet Oncology 2024 · DOI

Abstract

Cancer Registry North-Rhine Westphalia.
BibTeX
@inproceedings{karpinski2024combining,
  author = {Madeleine J. Karpinski and Johannes Hüsing and Kevin Claaßen and Lennart Möller and Hiltraud Kajüter and Florian Oesterling and Viktor Grünwald and Lale Umutlu and Jens Kleesiek and Tuğçe Telli and Anja Merkel‐Jens and Anika Hüsing and Claudia Kesch and Ken Herrmann and Matthias Eiber and Sebastian Hoberück and Philipp T. Meyer and Felix Kind and Kambiz Rahbar and Michael Schäfers and Andreas Stang and Boris Hadaschik and Wolfgang P. Fendler},
  title = {{Combining PSMA-PET and PROMISE to re-define disease stage and risk in patients with prostate cancer: a multicentre retrospective study}},
  booktitle = {The Lancet Oncology},
  year = {2024},
  doi = {10.1016/s1470-2045(24)00326-7},
}

Loading related content...

Figure